Blog Articles Proactive Safety Monitoring in ADC Oncology Trials: Implementing Structured HRCT Surveillance for ILDAntibody-Drug Conjugates (ADCs) represent one of the most promising frontiers in modern oncology. However, their unique mechanisms of action require equally specialized safety monitoring. Among these considerations, ADC-related Interstitial Lung… Read more Imaging Response Assessment in Immuno‑Oncology: Navigating an Evolving LandscapeImmuno-oncology (IO) has transformed cancer therapy, introducing durable responses across a range of tumor types. However, it has also made imaging response assessment in immuno-oncology more complex. Traditional radiologic frameworks… Read more How to Integrate Ocular Safety Into Clinical Trials: A Step‑by‑Step GuideSystemic therapies across oncology, neurology, infectious disease, and cardiovascular medicine can carry sight-threatening ocular risks. As regulatory expectations continue to emphasize early safety characterization of potential ophthalmic effects, even for… Read more
